Alemtuzumab induction versus conventional immunosuppression in heart transplant recipients

被引：0
|
作者：
Leelathanalerk, Areerut [1 ]
Ingviya, Thammasin [2 ]
Ivaturi, Vijay [1 ]
Reed, Brent N. [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
451
引用
收藏
页码：E292 / E293
页数：2
相关论文
共 50 条
  • [21] Racial Disparities in Induction Immunosuppression Use Among Heart Transplant Recipients in the United States
    Salia, Soziema J.
    Mostofsky, Elizabeth
    Gupta, Suruchi
    Lehman, Laura L.
    Motiwala, Shweta R.
    Mittleman, Murray A. Murray
    CIRCULATION, 2021, 144
  • [22] Should heart, lung, and liver transplant recipients receive immunosuppression induction for kidney transplantation?
    Ranney, D. N.
    Englesbe, M. J.
    Muhammad, W.
    Al-Holou, S. N.
    Park, J. M.
    Pelletier, S. J.
    Punch, J. D.
    Lynch, R. J.
    CLINICAL TRANSPLANTATION, 2010, 24 (01) : 67 - 72
  • [23] Alemtuzumab induction therapy in highly sensitized kidney transplant recipients
    L Tie-ming
    YANG Shun-liang
    WU Wei-zhen
    TAN Jian-ming
    中华医学杂志（英文版）, 2011, (05) : 664 - 668
  • [24] Alemtuzumab Induction in HCV Seropositive Kidney Transplant Recipients.
    Vivanco, M.
    Friedman, P.
    Xia, Y.
    Klair, T.
    Marfu, K.
    De Boccardo, G.
    Greenstein, S.
    Chapochnick, J.
    Kinkhabwala, M.
    Akalin, E.
    Kayler, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 428 - 428
  • [25] BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression
    Korneffel, Katie
    Gehring, Bradley
    Rospert, Daniel
    Rees, Michael
    Ortiz, Jorge
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (05) : 557 - 563
  • [26] Alemtuzumab induction therapy in highly sensitized kidney transplant recipients
    Lue Tie-ming
    Yang Shun-liang
    Wu Wei-zhen
    Tan Jian-ming
    CHINESE MEDICAL JOURNAL, 2011, 124 (05) : 664 - 668
  • [27] Outcomes Using Alemtuzumab Induction in Pediatric Kidney Transplant Recipients
    Zhang Yifeng
    Kumar, Juhi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [28] Alemtuzumab Induction in Sensitized, Kidney Re-Transplant Recipients
    Shaffer, I.
    Hale, D.
    Moore, D.
    Schaefer, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 251 - 251
  • [29] Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.
    Yakubu, I.
    Masters, B.
    Ravichandran, B.
    Sparkes, T.
    Moss, M.
    Rasetto, F.
    Jonchhe, S.
    Thomas, B.
    Costa, N.
    Leeser, D.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 614
  • [30] Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients
    Bank, J.
    Mallat, M.
    van der Boog, P.
    Braat, D.
    Ringers, J.
    Vergunst, M.
    Heidt, S.
    Claas, F.
    Reinders, M.
    de Fijter, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345